logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hitoshi Kawasuji

toyama university graduate school of medicine and pharmaceutical sciences
H指数:14
被引数:729

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Utility of risk assessment and identification of risk factors for drug-resistant pathogens in hospital-acquired and ventilator-associated pneumonia: systematic reviews and meta-analyses

医院获得性和呼吸机相关性肺炎中耐药病原体的风险评估和风险因素识别的效用：系统评价和荟萃分析

Respiratory Investigation
IF2
2026-05-010
PRE
Kawasuji, Hitoshi; Maruyama, Takaya; Aoki, Nobumasa; Koshiyama, Yuki; Nagaoka, Kentaro; Katsurada, Masahiro; Sano, Masahiro; Shindo, Yuichiro; Iwanaga, Naoki; Horita, Nobuyuki; Tsukada, Hiroki; Matsumoto, Tetsuya; Mukae, Hiroshi; Yamamoto, Yoshihiro
Clindamycin demonstrates clinical effectiveness for bacteremic M1UK Streptococcus pyogenes pneumonia: A case report and in vitro evidence of notable antitoxin effects on M1UK

克林霉素对菌血症性M1UK化脓性链球菌肺炎显示出临床疗效：病例报告及体外证据表明其对M1UK具有显著的抗毒素作用

International Journal of Infectious Diseases
IF4.3
2026-04-270
OAAI
Masayoshi Ezaki; Tien Manh Nguyen; Hitoshi Kawasuji; Kentaro Nagaoka; Yusuke Takegoshi; Kaho Ikeda; Junichi Kanatani; Kazunori Oishi; Yoshitomo Morinaga; Yoshihiro Yamamoto
High feasibility of salivary therapeutic drug monitoring in linezolid, but lower feasibility in tedizolid: a single-dose study in healthy subjects and a monocentric prospective exploratory study in patients who received linezolid

唾液治疗药物监测在利奈唑胺中具有高度可行性，但在 tedizolid 中可行性较低：一项在健康受试者中进行的单剂量研究以及一项在接收利奈唑胺治疗的患者中进行的单中心前瞻性探索性研究。

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
IF3.6
2025-07-010
PRE
Kawasuji, Hitoshi; Tsuji, Yasuhiro; Miyaki, Keiko; Aoyama, Takahiko; Kurosaki, Fumihiro; Ezaki, Masayoshi; Koshiyama, Yuki; Takegoshi, Yusuke; Kaneda, Makito; Murai, Yushi; Kimoto, Kou; Nagaoka, Kentaro; Yamamoto, Yoshihiro
Clinical phenotype of anaerobic bacteremia unaccompanied by detectable abscess lesion: a 10-year retrospective, multicenter, observational-cohort study

厌氧性菌血症不伴有可检测的脓肿病变的临床表型: 一项为期10年的回顾性、多中心、观察性队列研究

INFECTION
IF3.6
2024-05-201
PRE
Nagaoka, Kentaro; Iwanaga, Naoki; Murai, Yushi; Kawasuji, Hitoshi; Miura, Masayoshi; Sato, Yukihiro; Ito, Hiroyuki; Terasaki, Yasushi; Takazono, Takahiro; Kosai, Kosuke; Sugano, Aki; Morinaga, Yoshitomo; Yanagihara, Katsunori; Mukae, Hiroshi; Yamamoto, Yoshihiro
High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection

新型冠状病毒肺炎肺炎诱导的高interleukin-6水平与Omicron突破性感染急性期循环滤泡辅助T细胞频率增加和强中和抗体反应相关

FRONTIERS IN IMMUNOLOGY
IF5.9
2024-04-171
OAAI
Kawasuji, Hitoshi; Morinaga, Yoshitomo; Nagaoka, Kentaro; Tani, Hideki; Yoshida, Yoshihiro; Yamada, Hiroshi; Takegoshi, Yusuke; Kaneda, Makito; Murai, Yushi; Kimoto, Kou; Niimi, Hideki; Yamamoto, Yoshihiro
Mortality risk factors and fulminant sub-phenotype in anaerobic bacteremia: a 10-year retrospective, multicenter, observational cohort study

厌氧菌血症的死亡率危险因素和暴发性亚表型: 一项为期10年的回顾性，多中心，观察性队列研究

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
IF3
2024-01-033
PRE
Nagaoka, Kentaro; Iwanaga, N.; Takegoshi, Y.; Murai, Y.; Kawasuji, H.; Miura, M.; Sato, Y.; Hatakeyama, Y.; Ito, H.; Kato, Y.; Shibayama, N.; Terasaki, Y.; Fujimura, T.; Takazono, T.; Kosai, K.; Sugano, A.; Morinaga, Y.; Yanagihara, K.; Mukae, H.; Yamamoto, Y.
A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19
MICROBIOLOGY SPECTRUM
IF3.8
2023-06-152
OAAI
Miyazaki, Taiga; Hosogaya, Naoki; Fukushige, Yuri; Takemori, Sachiko; Morimoto, Shinpei; Yamamoto, Hiroshi; Hori, Makoto; Ozawa, Yoshihito; Shiko, Yuki; Inaba, Yosuke; Kurokawa, Tomoya; Hanaoka, Hideki; Iwanami, Shoya; Kim, Kwangsu; Iwami, Shingo; Watashi, Koichi; Miyazawa, Ken; Umeyama, Takashi; Yamagoe, Satoshi; Miyazaki, Yoshitsugu; Wakita, Takaji; Sumiyoshi, Makoto; Hirayama, Tatsuro; Izumikawa, Koichi; Yanagihara, Katsunori; Mukae, Hiroshi; Kawasuji, Hitoshi; Yamamoto, Yoshihiro; Tarumoto, Norihito; Ishii, Hiroshi; Ohno, Hideaki; Yatera, Kazuhiro; Kakeya, Hiroshi; Kichikawa, Yoshiko; Kato, Yasuyuki; Matsumoto, Tetsuya; Saito, Makoto; Yotsuyanagi, Hiroshi; Kohno, Shigeru
Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5

野生型/Omicron BA.1二价疫苗的中和抗体反应作为针对Omicron BA.2和BA.5的第二次加强剂量

MICROBIOLOGY SPECTRUM
IF3.8
2023-04-138
OAAI
Kawasuji, Hitoshi; Morinaga, Yoshitomo; Tani, Hideki; Saga, Yumiko; Yamada, Hiroshi; Yoshida, Yoshihiro; Takegoshi, Yusuke; Kaneda, Makito; Murai, Yushi; Kimoto, Kou; Ueno, Akitoshi; Miyajima, Yuki; Nagaoka, Kentaro; Ono, Chikako; Matsuura, Yoshiharu; Niimi, Hideki; Yamamoto, Yoshihiro
Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants

新型超中和抗体UT28K能够保护免受多种SARS-CoV-2变体的感染

MABS
IF7.3
2022-05-117
OAAI
Ozawa, Tatsuhiko; Tani, Hideki; Anraku, Yuki; Kita, Shunsuke; Igarashi, Emiko; Saga, Yumiko; Inasaki, Noriko; Kawasuji, Hitoshi; Yamada, Hiroshi; Sasaki, So-Ichiro; Somekawa, Mayu; Sasaki, Jiei; Hayakawa, Yoshihiro; Yamamoto, Yoshihiro; Morinaga, Yoshitomo; Kurosawa, Nobuyuki; Isobe, Masaharu; Fukuhara, Hideo; Maenaka, Katsumi; Hashiguchi, Takao; Kishi, Hiroyuki; Kitajima, Isao; Saito, Shigeru; Niimi, Hideki

研究方向

暂未获取到该数据
Y
Yoshihiro Yamamoto
H 指数:54论文数:688被引数:1.2万
Y
Yoshitomo Morinaga
H 指数:30论文数:308被引数:3,446
M
Makito Kaneda
H 指数:11论文数:52被引数:419
Y
Yushi Murai
H 指数:9论文数:36被引数:246
Y
Yusuke Takegoshi
H 指数:8论文数:43被引数:364
H
Hideki Tani
H 指数:38论文数:153被引数:5,445
K
Kou Kimoto
H 指数:8论文数:34被引数:228
K
Kentaro Nagaoka
H 指数:12论文数:70被引数:486
H
Hiroshi Yamada
H 指数:35论文数:224被引数:4,426
H
Hideki Niimi
H 指数:16论文数:101被引数:1,352